---
company: HAWKINS INC
ticker: HWKN
form: 8-K
filed: 2026-07-29
accession: 0000046250-26-000033
source: https://www.sec.gov/Archives/edgar/data/46250/000004625026000033/
---

# Hawkins (HWKN) earnings release, July 29, 2026

Hawkins Inc (HWKN) · Form 8-K, Item 2.02 · Filed 2026-07-29 · [SEC filing](https://www.sec.gov/Archives/edgar/data/46250/000004625026000033/)

Hawkins, Inc. Reports

First Quarter Fiscal 2027 Results

Roseville, Minn., July 29, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three months ended June 28, 2026, its first quarter of fiscal 2027.

First Quarter Fiscal Year 2027 Highlights:

(All comparisons are to the first quarter of fiscal 2026 unless otherwise noted.)

• Record first quarter revenue of $315.7 million, with growth of 8%, driven by increased sales across all segments, including Water Treatment segment growth of 6%, Food & Health Sciences segment growth of 9%, and Industrial Solutions segment growth of 10%.

• Record first quarter gross profit of $74.0 million, an increase of 2%.

• Diluted earnings per share ("EPS") of $1.35 decreased $0.05, or 4%.

• Net income of $28.3 million decreased 3%, with trailing twelve-month net income of $80.6 million. Record Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $56.9 million, a 1% increase. Trailing twelve-month adjusted EBITDA of $179.8 million.

• Generated operating cash flow of $35.2 million, an increase of 12%. Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased over 30%, to $23.5 million, which we allocated to repurchasing $7.0 million of stock, paying $4.0 million in dividends, and acquiring Aqua-Chem, Inc. for $3.6 million.

• We continued to execute on our Water Treatment growth strategy with the purchase of Aqua-Chem, Inc., a distributor of water treatment products mainly in Nebraska and Iowa.

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“Our first quarter was a solid start to the year, highlighted by another quarter of record results in revenue, gross profit, and adjusted EBITDA” said Patrick Hawkins, Chief Executive Officer and President. “Our record revenue of $315.7 million was the result of all three reporting segments growing year over year, and included organic revenue growth of approximately 5%, consistent with our expectation of returning to historical organic revenue growth rates in fiscal 2027.”

Mr. Hawkins continued, “The first quarter brought raw material volatility. Our great team members stayed close to our suppliers and our customers, managing input costs while continuing to deliver the products and level of service expected from Hawkins. As we exited the quarter, raw material costs had largely stabilized.”

Mr. Hawkins concluded, “Our balance sheet remains strong, and our leverage ratio at the end of the first quarter was 1.36x adjusted EBITDA. We continue to generate strong free cash flow and we expect to continue to pay down debt during fiscal 2027. We will also continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and servicing the needs of our customers to the highest level possible.”

First Quarter Financial Highlights:

NET INCOME

For the first quarter of fiscal 2027, we reported net income of $28.3 million, or $1.35 per diluted share, compared to net income for the first quarter of fiscal 2026 of $29.2 million, or $1.40 per diluted share.

REVENUE

Sales were $315.7 million for the first quarter of fiscal 2027, an increase of $22.4 million, or 8%, from sales of $293.3 million in the same period a year ago. All of our segments grew by more than 5% from the same period a year ago.

Water Treatment segment sales increased $8.7 million, or 6%, to $158.3 million for the current quarter, from $149.6 million in the same period a year ago. Water Treatment sales increased as a result of $6.9 million of added sales from acquired businesses, as well as increased organic sales volumes and improved pricing on certain products in our legacy business, including continued growth in our proprietary product lines.

Food & Health Sciences segment sales increased $8.1 million, or 9%, to $97.3 million for the current quarter, from $89.2 million in the same period a year ago. Sales of our agricultural, nutrition, and pharmaceutical products all increased over the same period a year ago, partially offset by decreased sales volumes of our food ingredient products. Agricultural products remained a source of strength, with sales growth of 30% driven by higher volumes.

Industrial Solutions segment sales increased $5.6 million, or 10%, to $60.1 million for the current quarter, from $54.5 million in the same period a year ago. Industrial Solutions segment sales increased primarily as a result of increased sales volumes of certain of our manufactured, blended and repackaged products.

GROSS PROFIT

Gross profit increased $1.6 million, or 2%, to $74.0 million, or 23% of sales, for the current quarter, from $72.4 million, or 25% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million, a $1.3 million greater headwind than in the same period a year ago. In addition to the impact of the LIFO reserve, gross margin was pressured by higher freight costs of approximately $1.3 million that were not fully recovered through freight charges billed to customers.

Gross profit for the Water Treatment segment increased $1.7 million, or 4%, to $45.5 million, or 29% of sales, for the current quarter, from $43.7 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased by $0.5 million, a $0.3 million greater headwind than in the same period a year ago. The increase in gross profit was primarily driven by higher sales partially offset by higher LIFO and freight costs.... (truncated)es volumes was offset by higher LIFO and freight costs.

Gross profit for the Industrial Solutions segment of $9.2 million, or 15% of sales, for the current quarter, was relatively flat compared to $9.3 million, or 17% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million, a $0.5 million greater headwind than in the same period a year ago. The benefit of higher sales volumes was more than offset by higher LIFO and freight costs.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative (“SG&A”) expenses increased $4.3 million, or 14%, to $35.3 million, or 11% of sales, for the current quarter, from $31.0 million, or 11% of sales, in the same period a year ago. This included $2.1 million due to added costs from the acquired businesses in our Water Treatment segment. In addition, the prior-year period included a $1.9 million favorable fair value adjustment that reduced SG&A, reflecting a downward revision to the estimated Water Solutions earnout liability based on a change in projected estimates related to the earnout target. This benefit did not recur in the current period, resulting in a $1.9 million year-over-year increase in SG&A. SG&A also included a $0.5 million incremental increase in non-qualified deferred compensation expense, which was offset by a corresponding gain within other income. These increases were partially offset by lower acquisition-related costs and other changes across our operating expenses.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended June 28, 2026 was $56.9 million, an increase of $0.8 million, or 1%, from $56.1 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended June 29, 2025 was $57.6 million, which included non-cash earnout related income that is excluded under the current definition.

INCOME TAXES

Our effective income tax rate was 24% for the current quarter and 25% for the same period a year ago. The effective tax rate in both years was impacted by favorable tax provision adjustments recorded. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is expected to be approximately 25% to 27%.

## Financial statements

### Income Statement (Adjusted EBITDA (in thousands))

| | Three months ended – June 28, 2026 | Three months ended – June 29, 2025 | Trailing twelve months ended – June 28, 2026 | Trailing twelve months ended – June 29, 2025 |
|---|---:|---:|---:|---:|
| Net Income (GAAP) | 28,254 | 29,175 | 80,627 | 84,641 |
| Interest expense, net | 2,773 | 3,269 | 13,011 | 7,438 |
| Income tax expense | 9,070 | 9,831 | 27,031 | 30,061 |
| Amortization of intangibles | 5,516 | 4,821 | 21,987 | 14,783 |
| Depreciation expense | 8,429 | 7,470 | 32,209 | 28,127 |
| Non-cash compensation expense | 2,235 | 2,212 | 8,596 | 7,243 |
| Non-recurring acquisition expenses (1) | 63 | 870 | 432 | 1,911 |
| Non-cash earnout related expense (income) | 535 | -1,583 | -4,059 | -553 |
| Adjusted EBITDA | 56,875 | 56,065 | 179,834 | 173,651 |

### Income Statement (Three months ended — (In thousands, except share and per-share data))

| | Three months ended – June 28, 2026 | Three months ended – June 29, 2025 |
|---|---:|---:|
| Sales | 315,675 | 293,272 |
| Cost of sales | -241,668 | -220,910 |
| Gross profit | 74,007 | 72,362 |
| Selling, general and administrative expenses | -35,335 | -31,029 |
| Operating income | 38,672 | 41,333 |
| Interest expense, net | -2,773 | -3,269 |
| Other income | 1,425 | 942 |
| Income before income taxes | 37,324 | 39,006 |
| Income tax expense | -9,070 | -9,831 |
| Net income | 28,254 | 29,175 |
| Weighted average number of shares outstanding - basic | 20,777,481 | 20,717,485 |
| Weighted average number of shares outstanding - diluted | 20,853,991 | 20,810,562 |
| Basic earnings per share | 1.36 | 1.41 |
| Diluted earnings per share | 1.35 | 1.4 |
| Cash dividends declared per common share | 0.19 | 0.18 |

### Income Statement (Water Treatment — (In thousands) (in thousands))

| | Three months ended June 28, 2026: – Water Treatment | Three months ended June 28, 2026: – Food & Health Sciences | Three months ended June 28, 2026: – Industrial Solutions | Three months ended June 28, 2026: – Total |
|---|---:|---:|---:|---:|
| Sales | 158,293 | 97,250 | 60,132 | 315,675 |
| Cost of sales - materials | -94,481 | -73,345 | -47,858 | -215,684 |
| Cost of sales - operational overhead | -18,316 | -4,630 | -3,038 | -25,984 |
| Gross profit | 45,496 | 19,275 | 9,236 | 74,007 |
| Selling, general, and administrative expenses | -23,670 | -8,028 | -3,637 | -35,335 |
| Operating income | 21,826 | 11,247 | 5,599 | 38,672 |
| Three months ended June 29, 2025: | Sales | 149,566 | 89,177 | 54,529 | 293,272 |
| Three months ended June 29, 2025: | Cost of sales - materials | -89,159 | -65,814 | -42,848 | -197,821 |
| Three months ended June 29, 2025: | Cost of sales - operational overhead | -16,660 | -4,015 | -2,414 | -23,089 |
| Three months ended June 29, 2025: | Gross profit | 43,747 | 19,348 | 9,267 | 72,362 |
| Three months ended June 29, 2025: | Selling, general, and administrative expenses | -19,085 | -8,381 | -3,563 | -31,029 |
| Three months ended June 29, 2025: | Operating income | 24,662 | 10,967 | 5,704 | 41,333 |

### Balance Sheet ((In thousands, except share data))

| | June 28, 2026 | March 29, 2026 |
|---|---:|---:|
| CURRENT ASSETS: | Cash and cash equivalents | 7,977 | 3,914 |
| CURRENT ASSETS: | Trade accounts receivables, net | 151,773 | 139,796 |
| CURRENT ASSETS: | Inventories | 79,864 | 78,199 |
| CURRENT ASSETS: | Prepaid expenses and other current assets | 9,165 | 9,556 |
| CURRENT ASSETS: | Total current assets | 248,779 | 231,465 |
| CURRENT ASSETS: | Property, plant, and equipment | 501,792 | 489,662 |
| CURRENT ASSETS: | Less accumulated depreciation | 231,206 | 223,406 |
| CURRENT ASSETS: | Net property, plant, and equipment | 270,586 | 266,256 |
| OTHER ASSETS: | Right-of-use assets | 16,081 | 16,840 |
| OTHER ASSETS: | Goodwill | 223,828 | 223,042 |
| OTHER ASSETS: | Intangible assets, net | 229,018 | 232,887 |
| OTHER ASSETS: | Deferred compensation plan asset | 16,477 | 12,812 |
| OTHER ASSETS: | Other | 1,474 | 2,988 |
| OTHER ASSETS: | Total other assets | 486,878 | 488,569 |
| OTHER ASSETS: | Total assets | 1,006,243 | 986,290 |
| CURRENT LIABILITIES: | Accounts payable — trade | 62,845 | 59,835 |
| CURRENT LIABILITIES: | Accrued payroll and employee benefits | 15,750 | 20,092 |
| CURRENT LIABILITIES: | Income tax payable | 8,236 | 98 |
| CURRENT LIABILITIES: | Environmental remediation | 7,700 | 7,700 |
| CURRENT LIABILITIES: | Other current liabilities (Note 8) | 15,083 | 17,119 |
| CURRENT LIABILITIES: | Total current liabilities | 109,614 | 104,844 |
| LONG-TERM LIABILITIES: | Long-term debt | 244,000 | 244,000 |
| LONG-TERM LIABILITIES: | Long-term lease liabilities | 13,703 | 14,457 |
| LONG-TERM LIABILITIES: | Pension withdrawal liability | 2,663 | 2,763 |
| LONG-TERM LIABILITIES: | Deferred income taxes | 25,065 | 25,110 |
| LONG-TERM LIABILITIES: | Deferred compensation liability | 17,330 | 14,850 |
| LONG-TERM LIABILITIES: | Earnout liabilities | 45,433 | 44,898 |
| LONG-TERM LIABILITIES: | Other long-term liabilities | 231 | 1,359 |
| LONG-TERM LIABILITIES: | Total long-term liabilities | 348,425 | 347,437 |
| LONG-TERM LIABILITIES: | Total liabilities | 458,039 | 452,281 |
| SHAREHOLDERS' EQUITY: | Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,743,884 and 20,752,138 shares issued and outstanding as of June 28, 2026 and March 29, 2026, respectively | 207 | 208 |
| SHAREHOLDERS' EQUITY: | Additional paid-in capital | 22,750 | 32,678 |
| SHAREHOLDERS' EQUITY: | Retained earnings | 524,425 | 500,142 |
| SHAREHOLDERS' EQUITY: | Accumulated other comprehensive income | 822 | 981 |
| SHAREHOLDERS' EQUITY: | Total shareholders’ equity | 548,204 | 534,009 |
| SHAREHOLDERS' EQUITY: | Total liabilities and shareholders’ equity | 1,006,243 | 986,290 |

### Cash Flow (Free Cash Flow Reconciliation (in thousands))

| | Three months ended – June 28, 2026 | Three months ended – June 29, 2025 |
|---|---:|---:|
| Net cash provided by operating activities | 35,152 | 31,490 |
| Less: Purchases of property, plant & equipment | -11,605 | -13,544 |
| Free cash flow | 23,547 | 17,946 |

### Cash Flow (Three months ended — (In thousands) (in thousands))

| | Three months ended – June 28, 2026 | Three months ended – June 29, 2025 |
|---|---:|---:|
| CASH FLOWS FROM OPERATING ACTIVITIES: | Net income | 28,254 | 29,175 |
